Loading…
Lobbying Spend
—
Filings
27
Firms Hired
1
Active Period
2014–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Consolidated Appropriations Act, 2023
2022 · fourth_quarter · Firm: Polsinelli PC
- Issues pertaining to the use of human tissues in the drug development process - HR 7667/S 4348 Food and Drug Administration Safety and Landmark Advancements - H.R. 2617 -- Consolidated Appropriations Act, 2023
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2617
- Issues pertaining to the use of human tissues in the drug development process - HR 7667/S 4348 Food and Drug Administration Safety and Landmark Advancements - H.R. 2617 -- Consolidated Appropriations Act, 2023
Client expense: — · Firm income: $30,000
Matched citations: HR 7667
- Issues pertaining to the use of human tissues in the drug development process - HR 7667/S 4348 Food and Drug Administration Safety and Landmark Advancements - H.R. 2617 -- Consolidated Appropriations Act, 2023
Client expense: — · Firm income: $30,000
Matched citations: S 4348
- Issues pertaining to the use of human tissues in the drug development process - HR 7667/S 4348 Food and Drug Administration Safety and Landmark Advancements
Client expense: — · Firm income: $30,000
Matched citations: HR 7667
- Issues pertaining to the use of human tissues in the drug development process - HR 7667/S 4348 Food and Drug Administration Safety and Landmark Advancements
Client expense: — · Firm income: $30,000
Matched citations: S 4348
- Issues pertaining to the use of human tissues in the drug development process - HR 7667/S 4348 Food and Drug Administration Safety and Landmark Advancements
Client expense: — · Firm income: $30,000
Matched citations: HR 7667
- Issues pertaining to the use of human tissues in the drug development process - HR 7667/S 4348 Food and Drug Administration Safety and Landmark Advancements
Client expense: — · Firm income: $30,000
Matched citations: S 4348
H.R. 6 - 21st Century Cures Act Developing a range of tissue and disease models for medical research and therapeutic applications
Client expense: — · Firm income: $20,000
Matched citations: H.R. 6
H.R. 6 - 21st Century Cures Act Developing a range of tissue and disease models for medical research and therapeutic applications
Client expense: — · Firm income: $20,000
Matched citations: H.R. 6
H.R. 6 - 21st Century Cures Act Developing a range of tissue and disease models for medical research and therapeutic applications
Client expense: — · Firm income: $30,000
Matched citations: H.R. 6
H.R. 6 - 21st Century Cures Act Developing a range of tissue and disease models for medical research and therapeutic applications
Client expense: — · Firm income: $10,000
Matched citations: H.R. 6
Source: Senate LDA